|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,620,000 |
Market
Cap: |
203.86(M) |
Last
Volume: |
14,666 |
Avg
Vol: |
14,625 |
52
Week Range: |
$3.05 - $7.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile MEI Pharma is a late-stage pharmaceutical company focused on the development and commercialization of cancer therapies to improve outcomes for patients. Co.'s portfolio of drug candidates includes three clinical-stage assets, including: Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase 9 inhibitor; and ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
336,100 |
417,600 |
Total Buy Value |
$0 |
$0 |
$2,112,595 |
$2,130,933 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
6 |
7 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ratcliffe Liam |
10% Owner |
|
2014-12-09 |
4 |
S |
$6.01 |
$421,082 |
D/D |
(70,081) |
1,601,390 |
|
- |
|
Ratcliffe Liam |
10% Owner |
|
2014-12-08 |
4 |
S |
$6.05 |
$54,495 |
D/D |
(9,004) |
1,671,471 |
|
- |
|
Baltic Charles V. Iii |
Director |
|
2014-06-30 |
4 |
B |
$6.60 |
$6,270 |
I/I |
950 |
3,850 |
2.1 |
- |
|
Baltic Charles V. Iii |
Director |
|
2014-06-30 |
4 |
B |
$6.52 |
$6,846 |
D/D |
1,050 |
17,750 |
2.39 |
- |
|
Ratcliffe Liam |
10% Owner |
|
2013-11-21 |
4 |
S |
$8.25 |
$3,011,250 |
D/D |
(365,000) |
1,680,475 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-10-29 |
4 |
S |
$8.27 |
$6,252 |
I/I |
(756) |
3,098,503 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-10-29 |
4 |
S |
$8.27 |
$364 |
I/I |
(44) |
180,015 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-10-28 |
4 |
S |
$8.30 |
$323,435 |
I/I |
(38,953) |
3,099,259 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-10-28 |
4 |
S |
$8.30 |
$18,790 |
I/I |
(2,263) |
180,059 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-10-25 |
4 |
S |
$8.20 |
$2,131,180 |
I/I |
(259,900) |
3,138,212 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-10-25 |
4 |
S |
$8.20 |
$123,820 |
I/I |
(15,100) |
182,322 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-10-02 |
4 |
S |
$10.00 |
$4,861,507 |
I/I |
(486,107) |
3,398,112 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-10-02 |
4 |
S |
$10.00 |
$282,455 |
I/I |
(28,243) |
197,422 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-10-01 |
4 |
S |
$11.00 |
$1,050,671 |
I/I |
(95,539) |
3,884,219 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-10-01 |
4 |
S |
$11.00 |
$61,046 |
I/I |
(5,551) |
225,665 |
|
- |
|
Baltic Charles V. Iii |
Director |
|
2013-08-16 |
4 |
B |
$6.82 |
$8,184 |
I/I |
1,200 |
2,900 |
2.1 |
- |
|
Baltic Charles V. Iii |
Director |
|
2013-08-16 |
4 |
B |
$6.82 |
$9,548 |
D/D |
1,400 |
16,700 |
2.39 |
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-06-28 |
4 |
S |
$7.58 |
$3,228 |
I/I |
(426) |
231,216 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-06-28 |
4 |
S |
$7.58 |
$55,598 |
I/I |
(7,337) |
3,979,758 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-06-11 |
4 |
S |
$7.80 |
$1,842,929 |
I/I |
(236,273) |
3,987,095 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-06-11 |
4 |
S |
$7.80 |
$107,071 |
I/I |
(13,727) |
231,642 |
|
- |
|
Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
|
2013-05-16 |
4 |
S |
$9.07 |
$9,174 |
I/I |
(1,012) |
245,369 |
|
- |
|
Vivo Ventures Vii Affiliates Fund, L.p. |
10% Owner |
|
2013-05-16 |
4 |
S |
$9.07 |
$157,994 |
I/I |
(17,428) |
4,223,368 |
|
- |
|
Delagardelle Jeani |
10% Owner |
|
2013-05-08 |
4 |
S |
$8.45 |
$845,000 |
D/D |
(100,000) |
2,045,475 |
|
- |
|
Delagardelle Jeani |
10% Owner |
|
2013-05-06 |
4 |
S |
$8.70 |
$870,000 |
D/D |
(100,000) |
2,145,475 |
|
- |
|
113 Records found
|
|
Page 3 of 5 |
|
|